| 25 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.9 |
5mg |
4.5mg |
-11.0% |
96.11% |
Lab B |
| 24 May 2026 |
MGF |
6.8 |
15mg |
17.5mg |
+16.6% |
98.14% |
Lab C |
| 24 May 2026 |
Vilon |
6.8 |
30mg |
29.5mg |
-1.8% |
98.99% |
Lab E |
| 24 May 2026 |
AICAR |
5.1 |
30mg |
26.9mg |
-10.5% |
99.76% |
Lab D |
| 24 May 2026 |
Andarine S4 |
8.3 |
25mg |
22.5mg |
-10.0% |
99.48% |
Lab D |
| 24 May 2026 |
Lipo-C FOCUS 425mg |
4.6 |
100mg/ml |
111.8mg/ml |
+11.8% |
99.36% |
Lab G |
| 24 May 2026 |
Primobolan Oral (Methenolone Acetate) |
4.6 |
25mg |
21.4mg |
-14.3% |
99.61% |
Lab F |
| 24 May 2026 |
Liraglutide |
4.2 |
2mg |
1.8mg |
-8.5% |
98.67% |
Lab E |
| 24 May 2026 |
Semax |
8.9 |
20mg |
23.3mg |
+16.3% |
99.05% |
Lab F |
| 24 May 2026 |
SHRED (L-Carnitine 200mg+B12+B6+Inositol+Methionine+Choline) |
6.3 |
250mg/ml |
282.6mg/ml |
+13.0% |
99.08% |
Lab D |
| 24 May 2026 |
T4 (Levothyroxine) |
7.4 |
20mg |
17.8mg |
-11.1% |
99.58% |
Lab D |
| 23 May 2026 |
Superdrol |
5.5 |
10mg |
10.5mg |
+5.2% |
96.03% |
Lab D |
| 23 May 2026 |
AHK-CU |
6.7 |
30mg |
33.6mg |
+11.9% |
95.75% |
Lab A |
| 22 May 2026 |
Retatrutide |
7.8 |
10mg |
9.74mg |
-2.6% |
99.84% |
No Label / Silver Crimp / Green Cap |
| 21 May 2026 |
Retatrutide |
7.0 |
10mg |
9.22mg |
-7.8% |
99.88% |
No Label / Silver Crimp / Yellow Cap |
| 21 May 2026 |
RIPEX 225 (TRA/Mast P/Test P) |
4.3 |
100mg/ml |
100.5mg/ml |
+0.5% |
98.09% |
Lab A |
| 19 May 2026 |
BPC157 10mg + TB500 10mg Blend |
4.0 |
50mg |
51.8mg |
+3.5% |
97.06% |
Lab G |
| 17 May 2026 |
Retatrutide |
7.0 |
10mg |
10mg |
|
99.50% |
No Label / Silver Crimp / Clear Blue Cap |
| 17 May 2026 |
Retatrutide |
6.8 |
10mg |
10.3mg |
+3.0% |
99.40% |
No Label / Silver Crimp / Clear Blue Cap |
| 17 May 2026 |
Adipotide |
8.2 |
30mg |
35.1mg |
+16.9% |
95.49% |
Lab B |
| 29 Jan 2026 |
Dianabol Oil |
6.6 |
100mg/ml |
116.8mg/ml |
+16.8% |
98.27% |
Lab F |
| 29 Jan 2026 |
PTD-DBM |
4.1 |
50mg |
55.2mg |
+10.5% |
99.34% |
Lab C |
| 26 Jan 2026 |
Alprostadil |
4.0 |
5mg |
4.8mg |
-4.0% |
95.81% |
Lab B |
| 26 Jan 2026 |
Dutasteride |
4.0 |
50mg |
49.0mg |
-2.0% |
95.48% |
Lab E |
| 9 Jan 2026 |
CJC-1295 With DAC |
4.8 |
30mg |
31.1mg |
+3.8% |
97.78% |
Lab F |
| 9 Jan 2026 |
Crystagen |
6.7 |
20mg |
21.0mg |
+5.2% |
96.02% |
Lab F |
| 7 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
7.2 |
50mg |
52.3mg |
+4.7% |
97.87% |
Lab F |
| 7 Jan 2026 |
NandroMix 300 |
5.8 |
300mg/ml |
335.4mg/ml |
+11.8% |
96.86% |
Lab D |
| 6 Jan 2026 |
5-amino-1MQ |
6.2 |
5mg |
5.3mg |
+5.9% |
98.15% |
Lab B |
| 29 Dec 2025 |
GHRP-6 Acetate |
8.1 |
20mg |
22.9mg |
+14.5% |
97.08% |
Lab B |
| 29 Dec 2025 |
Trenbolone Enanthate |
6.4 |
300mg/ml |
338.7mg/ml |
+12.9% |
97.02% |
Lab D |
| 12 Dec 2025 |
Botulinum toxin |
5.1 |
50mg |
48.5mg |
-3.1% |
97.99% |
Lab C |
| 12 Dec 2025 |
N-Acetyl Epitalon Amidate |
4.3 |
30mg |
26.4mg |
-12.1% |
95.47% |
Lab E |
| 12 Dec 2025 |
Proviron (Mesterolone) |
6.6 |
10mg |
10.4mg |
+3.7% |
95.38% |
Lab D |
| 5 Dec 2025 |
Lipo-B 216mg |
7.7 |
100mg/ml |
112.5mg/ml |
+12.5% |
99.11% |
Lab D |
| 5 Dec 2025 |
Livagen |
4.6 |
5mg |
4.9mg |
-1.4% |
98.08% |
Lab G |
| 5 Dec 2025 |
SR9009 |
6.1 |
25mg |
23.1mg |
-7.5% |
97.00% |
Lab B |
| 23 Nov 2025 |
Retatrutide |
3.3 |
15mg |
21.7mg |
+44.7% |
99.30% |
White Label / Copper Crimp / Clear Cap |
| 14 Nov 2025 |
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg |
4.0 |
50mg |
62.5mg |
+24.9% |
99.22% |
Lab B |
| 14 Nov 2025 |
Test Suspension |
9.0 |
200mg/ml |
200.6mg/ml |
+0.3% |
97.31% |
Lab E |
| 5 Nov 2025 |
Sustanon 250 |
7.3 |
250mg/ml |
297.5mg/ml |
+19.0% |
98.86% |
Lab F |
| 4 Nov 2025 |
Oxytocin Acetate |
4.5 |
15mg |
14.8mg |
-1.6% |
95.03% |
Lab B |
| 4 Nov 2025 |
Selank 10mg + Semax 10mg Blend |
8.2 |
5mg |
5.6mg |
+12.7% |
97.02% |
Lab G |
| 9 Oct 2025 |
HMG |
8.4 |
50mg |
49.7mg |
-0.6% |
95.34% |
Lab D |
| 9 Oct 2025 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
9.9 |
100g |
122.3g |
+22.3% |
95.93% |
Lab A |
| 3 Oct 2025 |
Halotestin (Fluoxymesterone) |
5.5 |
10mg |
11.7mg |
+17.1% |
96.66% |
Lab C |